Free Trial

PaxMedica (PXMD) Stock Chart & Stock Price History

PaxMedica logo
$0.03 0.00 (0.00%)
As of 01/17/2025

PaxMedica Stock Price Performance

5 Day
Performance
0.00%
1 Month
Performance
-60.10%
3 Month
Performance
-77.86%
6 Month
Performance
-87.30%
Year-To-Date
Performance
-49.76%
1 Year
Performance
-94.54%
Receive PXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PaxMedica and its competitors with MarketBeat's FREE daily newsletter.

PXMD Stock Chart for Tuesday, January, 21, 2025

PaxMedica Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
01/21/2025$0.03$0.03$0.03$0.0319 shs$351,000.00
01/20/2025$0.03$0.03$0.03$0.0319 shs$351,000.00
01/17/2025$0.03$0.03$0.03$0.031,000 shs$351,000.00
01/16/2025$0.04$0.03
-22.50%
$0.03$0.031,000 shs$351,000.00
01/15/2025$0.05$0.04
-25.93%
$0.04$0.043,029 shs$452,000.00
01/14/2025$0.05$0.05
-0.37%
$0.06$0.0583,021 shs$611,000.00
01/13/2025$0.06$0.05
-7.19%
$0.06$0.049,095 shs$613,000.00
01/10/2025$0.06$0.06
-3.15%
$0.07$0.0446,340 shs$661,000.00
01/09/2025$0.06$0.06$0.07$0.0528,948 shs$682,000.00
01/08/2025$0.05$0.06
+13.99%
$0.07$0.0528,948 shs$682,000.00
01/07/2025$0.03$0.05
+75.75%
$0.07$0.0320,643 shs$598,000.00
01/06/2025$0.07$0.03
-53.91%
$0.07$0.03226,937 shs$340,000.00
01/03/2025$0.07$0.07
-2.54%
$0.07$0.068,841 shs$739,000.00
01/02/2025$0.06$0.07
+8.59%
$0.07$0.066,465 shs$758,000.00
01/01/2025$0.06$0.06$0.07$0.06168,902 shs$698,000.00
12/31/2024$0.06$0.06
-0.48%
$0.07$0.06168,902 shs$698,000.00
12/30/2024$0.06$0.06
-1.59%
$0.07$0.0655,670 shs$701,000.00
12/27/2024$0.07$0.06
-8.16%
$0.07$0.06160,606 shs$713,000.00
12/26/2024$0.06$0.07
+7.52%
$0.07$0.0721,103 shs$776,000.00
12/25/2024$0.06$0.06$0.08$0.065,562 shs$722,000.00
12/24/2024$0.07$0.06
-3.48%
$0.08$0.065,562 shs$722,000.00
12/23/2024$0.08$0.07
-14.93%
$0.07$0.06149,027 shs$748,000.00
12/20/2024$0.07$0.08
+5.00%
$0.08$0.0710,980 shs$879,000.00


This page (NASDAQ:PXMD) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners